Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription Articles published in Thorax Retrieve available abstracts of 61 articles: HTML format

Single Articles

May 2024
1. RAHMAN ML, Breeze CE, Shu XO, Wong JYY, et al
   Epigenome-wide association study of lung cancer among never smokers in two prospective cohorts in Shanghai, China.
   Thorax. 2024 May 3:thorax-2023-220352. doi: 10.1136/thorax-2023-220352.
   PubMed     Abstract available
   
   
   
2. CHRISTIANI DC
   Epigenetic clock as the new hand of time for lung cancer in never smokers.
   Thorax. 2024 May 3:thorax-2024-221393. doi: 10.1136/thorax-2024-221393.
   PubMed    
   
   
   April 2024
3. SHAH PL
   Ablation for lung cancer: hot or cold intervention.
   Thorax. 2024 Apr 4:thorax-2023-221369. doi: 10.1136/thorax-2023-221369.
   PubMed    
   
   
   March 2024
4. JACOBS C
   Decoding pulmonary nodules: can machine learning enhance malignancy risk stratification?
   Thorax. 2024;79:293-294.
   PubMed    
   
   
   
5. WARKENTIN MT, Al-Sawaihey H, Lam S, Liu G, et al
   Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches.
   Thorax. 2024;79:307-315.
   PubMed     Abstract available
   
   
   
6. ROSTOCK L, Holotiuk O, Ploenes T
   Well-differentiated papillary mesothelial tumour: a rare finding on the pleura.
   Thorax. 2024;79:380-381.
   PubMed    
   
   
   February 2024
7. DAFFRE E, Porcher R, Iannelli A, Prieto M, et al
   Protective effect of height on long-term survival of resectable lung cancer: a new feature of the lung cancer paradox.
   Thorax. 2024 Feb 15:thorax-2023-220443. doi: 10.1136/thorax-2023-220443.
   PubMed     Abstract available
   
   
   
8. KOO MM, Mounce LTA, Rafiq M, Callister MEJ, et al
   Guideline concordance for timely chest imaging after new presentations of dyspnoea or haemoptysis in primary care: a retrospective cohort study.
   Thorax. 2024;79:236-244.
   PubMed     Abstract available
   
   
   January 2024
9. WONG JY, Blechter B, Hubbard AK, Machiela MJ, et al
   Phenotypic and genetically predicted leucocyte telomere length and lung cancer risk in the prospective UK Biobank.
   Thorax. 2024 Jan 17:thorax-2023-220076. doi: 10.1136/thorax-2023-220076.
   PubMed     Abstract available
   
   
   
10. SMITH P, Murray RL, Crosbie PA
    Integrated stop smoking interventions are essential to maximise the health benefits from lung cancer screening.
    Thorax. 2024 Jan 12:thorax-2023-221037. doi: 10.1136/thorax-2023-221037.
    PubMed    
    
    
    
11. HICKMAN K
    Unmasking delays: bridging the gap in timely lung cancer diagnosis for UK primary care.
    Thorax. 2024 Jan 9:thorax-2023-220739. doi: 10.1136/thorax-2023-220739.
    PubMed    
    
    
    December 2023
12. LI Y, Chen W, Xie F, Huang R, et al
    Novel electromagnetic navigation bronchoscopy system for the diagnosis of peripheral pulmonary nodules: a prospective, multicentre study.
    Thorax. 2023;78:1197-1205.
    PubMed     Abstract available
    
    
    November 2023
13. MORGAN H, Gysling S, Navani N, Baldwin D, et al
    Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset.
    Thorax. 2023 Nov 6:thorax-2022-219593. doi: 10.1136/thorax-2022-219593.
    PubMed     Abstract available
    
    
    October 2023
14. FIELD JK
    Road map to improve the quality of lung cancer risk data.
    Thorax. 2023 Oct 25:thorax-2023-220784. doi: 10.1136/thorax-2023-220784.
    PubMed    
    
    
    
15. WILLIAMS PJ, Philip KEJ, Buttery SC, Perkins A, et al
    Immediate smoking cessation support during lung cancer screening: long-term outcomes from two randomised controlled trials.
    Thorax. 2023 Oct 24:thorax-2023-220367. doi: 10.1136/thorax-2023-220367.
    PubMed     Abstract available
    
    
    August 2023
16. GOODLEY P, Balata H, Alonso A, Brockelsby C, et al
    Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation.
    Thorax. 2023 Aug 16:thorax-2023-220001. doi: 10.1136/thorax-2023-220001.
    PubMed     Abstract available
    
    
    July 2023
17. NG WWS, Chin K, Lam SM
    Rare cause of massive haemoptysis diagnosed by ultrasonography in the ICU.
    Thorax. 2023;78:733-734.
    PubMed    
    
    
    
18. YOUNG RP, Ward RC, Scott RJ, Gamble GD, et al
    Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters.
    Thorax. 2023;78:690-697.
    PubMed     Abstract available
    
    
    June 2023
19. GRAU A, Lozano C, Gallego M
    Tracheal stenosis after endobronchial ultrasound-guided transbronchial needle aspiration.
    Thorax. 2023;78:631.
    PubMed    
    
    
    April 2023
20. DAWSON AG, Kutywayo K, Mohammed SB, Fennell DA, et al
    Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic review.
    Thorax. 2023;78:409-417.
    PubMed     Abstract available
    
    
    March 2023
21. BRADLEY C, Boland A, Clarke L, Dallinson N, et al
    Diagnosis and treatment outcomes from prebronchodilator spirometry performed alongside lung cancer screening in a Lung Health Check programme.
    Thorax. 2023 Mar 27:thorax-2022-219683. doi: 10.1136/thorax-2022-219683.
    PubMed     Abstract available
    
    
    
22. RUPAREL M
    Lung cancer screening in advanced chronic obstructive pulmonary disease: helpful or harmful?
    Thorax. 2023 Mar 21:thorax-2022-219778. doi: 10.1136/thorax-2022-219778.
    PubMed    
    
    
    
23. BENNETT K, Totton K, Misacas A, Caswell F, et al
    Transient visual loss following CT-guided percutaneous core needle biopsy of a lung lesion.
    Thorax. 2023;78:316-317.
    PubMed    
    
    
    February 2023
24. CHAUHAN NK, Rajagopal R, Shadrach BJ, Dutt N, et al
    Pulmonary arterio-venous malformation on endobronchial ultrasound bronchoscopy.
    Thorax. 2023;78:214-215.
    PubMed    
    
    
    January 2023
25. RUPAREL M
    Should we retain smaller growing nodules in lung cancer screening programmes for surveillance?
    Thorax. 2023 Jan 25:thorax-2022-219838. doi: 10.1136/thorax-2022-219838.
    PubMed    
    
    
    
26. DU Y, Guo M, Wu Y, Wagner A, et al
    Lymphangioleiomyomatosis (LAM) Cell Atlas.
    Thorax. 2023;78:85-87.
    PubMed     Abstract available
    
    
    
27. CARUANA E, Steiner MC
    Perioperative rehabilitation in thoracic surgery: get up and go!
    Thorax. 2023;78:1-2.
    PubMed    
    
    
    
28. KASSIRIAN S, Hinton SN, Cuninghame S, Chaudhary R, et al
    Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis.
    Thorax. 2023;78:32-40.
    PubMed     Abstract available
    
    
    December 2022
29. RAMOS-ESQUIVEL A
    Immunotherapy in non-small-cell lung cancer: new data support its use, but some challenges remain.
    Thorax. 2022;77:1159-1160.
    PubMed    
    
    
    
30. VAN KOOTEN JP, Belderbos RA, von der Thusen JH, Aarts MJ, et al
    Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.
    Thorax. 2022;77:1260-1267.
    PubMed     Abstract available
    
    
    
31. KIDD AC, Anderson O, Cowell GW, Weir AJ, et al
    Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria.
    Thorax. 2022;77:1251-1259.
    PubMed     Abstract available
    
    
    November 2022
32. CREAMER AW, Horst C, Dickson JL, Tisi S, et al
    Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm(3) minimum size threshold for multidisciplinary team referral.
    Thorax. 2022 Nov 25:thorax-2022-219403. doi: 10.1136/thorax-2022-219403.
    PubMed     Abstract available
    
    
    
33. AZZOLINA D, Consonni D, Ferrante D, Mirabelli D, et al
    Rate advancement measurement for lung cancer and pleural mesothelioma in asbestos-exposed workers.
    Thorax. 2022 Nov 10. pii: thorax-2021-217862. doi: 10.1136/thorax-2021-217862.
    PubMed     Abstract available
    
    
    
34. WOZNITZA N, Ghimire B, Devaraj A, Janes SM, et al
    Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial.
    Thorax. 2022 Nov 8. pii: thorax-2022-219210. doi: 10.1136/thorax-2022-219210.
    PubMed     Abstract available
    
    
    
35. TANAKA H, Kabata H, Emoto K, Hayashi S, et al
    Young woman with multiple lung nodules: a pulmonary oxymoron.
    Thorax. 2022;77:1155-1157.
    PubMed    
    
    
    October 2022
36. ROSE JA, Hunninghake GM
    Time to move out of the shadows: ILA in patients with lung cancer.
    Thorax. 2022 Oct 21. pii: thorax-2022-219498. doi: 10.1136/thorax-2022-219498.
    PubMed    
    
    
    August 2022
37. HEWITT RJ, Bartlett EC, Ganatra R, Butt H, et al
    Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease.
    Thorax. 2022 Aug 8. pii: thorax-2022-219068. doi: 10.1136/thorax-2022-219068.
    PubMed     Abstract available
    
    
    July 2022
38. DICKSON JL, Hall H, Horst C, Tisi S, et al
    Telephone risk-based eligibility assessment for low-dose CT lung cancer screening.
    Thorax. 2022 Jul 21. pii: thoraxjnl-2021-218634.
    PubMed     Abstract available
    
    
    
39. ZHENG Y, Mao M, Li F, Wang L, et al
    Effects of enhanced recovery after surgery plus pulmonary rehabilitation on complications after video-assisted lung cancer surgery: a multicentre randomised controlled trial.
    Thorax. 2022 Jul 14. pii: thoraxjnl-2021-218183.
    PubMed     Abstract available
    
    
    June 2022
40. KANABAR SS, Tiwari A, Soran V, Balendran P, et al
    Impact of PD1 and PDL1 immunotherapy on non-small cell lung cancer outcomes: a systematic review.
    Thorax. 2022 Jun 10. pii: thoraxjnl-2020-215614.
    PubMed     Abstract available
    
    
    
41. IM Y, Chung MP, Lee KS, Han J, et al
    Impact of interstitial lung abnormalities on postoperative pulmonary complications and survival of lung cancer.
    Thorax. 2022 Jun 10. pii: thoraxjnl-2021-218055.
    PubMed     Abstract available
    
    
    May 2022
42. HESSEL PA
    Mesothelioma among vehicle mechanics: a controversy?
    Thorax. 2022;77:426-427.
    PubMed    
    
    
    
43. THOMSEN RW, Riis AH, Flachs EM, Garabrant DH, et al
    Risk of asbestosis, mesothelioma, other lung disease or death among motor vehicle mechanics: a 45-year Danish cohort study.
    Thorax. 2022;77:477-485.
    PubMed     Abstract available
    
    
    April 2022
44. MORGAN H, Baldwin D, Hubbard R, Navani N, et al
    Ninety-day mortality following lung cancer surgery: outcomes from the English national clinical outcomes audit.
    Thorax. 2022 Apr 28. pii: thoraxjnl-2021-218308.
    PubMed     Abstract available
    
    
    
45. KLARENBEEK SE, Aarts MJ, van den Heuvel MM, Prokop M, et al
    Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study.
    Thorax. 2022 Apr 21. pii: thoraxjnl-2021-218059.
    PubMed     Abstract available
    
    
    March 2022
46. NAOI H, Suzuki Y, Mori K, Aono Y, et al
    Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
    Thorax. 2022 Mar 30. pii: thoraxjnl-2021-218281.
    PubMed     Abstract available
    
    
    
47. NARAN R, Dattani V, Madani Y
    Lemierre's syndrome masking metastatic lung adenocarcinoma.
    Thorax. 2022;77:314-316.
    PubMed    
    
    
    December 2021
48. LEEM G, Jeon M, Kim KW, Jeong S, et al
    Tumour-infiltrating bystander CD8(+) T cells activated by IL-15 contribute to tumour control in non-small cell lung cancer.
    Thorax. 2021 Dec 1. pii: thoraxjnl-2021-217001.
    PubMed     Abstract available
    
    
    November 2021
49. SHAMSEDDIN M, Obacz J, Garnett MJ, Rintoul RC, et al
    Use of preclinical models for malignant pleural mesothelioma.
    Thorax. 2021;76:1154-1162.
    PubMed     Abstract available
    
    
    October 2021
50. O'DOWD EL, Ten Haaf K, Kaur J, Duffy SW, et al
    Selection of eligible participants for screening for lung cancer using primary care data.
    Thorax. 2021 Oct 29. pii: thoraxjnl-2021-217142.
    PubMed     Abstract available
    
    
    
51. PERLEPE G, Kotsiou OS, Karetsi E, Papadopoulos D, et al
    Persistent consolidation: a MALT-easer.
    Thorax. 2021;76:1057-1059.
    PubMed    
    
    
    
52. BARNES-HARRIS M, Allingham S, Morgan D, Ferreira D, et al
    Comparing functional decline and distress from symptoms in people with thoracic life-limiting illnesses: lung cancers and non-malignant end-stage respiratory diseases.
    Thorax. 2021;76:989-995.
    PubMed     Abstract available
    
    
    August 2021
53. GRAVIER FE, Smondack P, Prieur G, Medrinal C, et al
    Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis.
    Thorax. 2021 Aug 24. pii: thoraxjnl-2021-217242.
    PubMed     Abstract available
    
    
    
54. HALL H, Tocock A, Burdett S, Fisher D, et al
    Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review.
    Thorax. 2021 Aug 17. pii: thoraxjnl-2021-216865.
    PubMed     Abstract available
    
    
    July 2021
55. ARAGHI M, Fidler-Benaoudia M, Arnold M, Rutherford M, et al
    International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
    Thorax. 2021 Jul 19. pii: thoraxjnl-2020-216555.
    PubMed     Abstract available
    
    
    June 2021
56. KRAMER T, Wijmans L, de Bruin M, van Leeuwen T, et al
    Bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time detection tool for peripheral lung cancer.
    Thorax. 2021 Jun 25. pii: thoraxjnl-2021-216885.
    PubMed     Abstract available
    
    
    May 2021
57. ZENG L, Xu Q, Yang N, Lizaso A, et al
    Third left pulmonary lobe.
    Thorax. 2021;76:525.
    PubMed    
    
    
    April 2021
58. NASR E, MacRae S, Dobson M, Russell D, et al
    A rare condition masquerading as lung cancer.
    Thorax. 2021 Apr 26. pii: thoraxjnl-2020-216689.
    PubMed    
    
    
    
59. VISSER S, Koolen S, van Donk N, van Walree N, et al
    Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer.
    Thorax. 2021 Apr 15. pii: thoraxjnl-2020-216504.
    PubMed     Abstract available
    
    
    
60. KIM YW, Kwon BS, Lim SY, Lee YJ, et al
    Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening.
    Thorax. 2021 Apr 15. pii: thoraxjnl-2020-215107.
    PubMed     Abstract available
    
    
    February 2021
61. TAN VSR, Li A, Seet JE, Lee P, et al
    Metastases from tracheal adenoid cystic carcinoma.
    Thorax. 2021;76:208-209.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.